University of Sydney, Faculty of Veterinary Science, Camden, NSW 2570, Australia.
Vaccine. 2011 Apr 27;29(19):3571-82. doi: 10.1016/j.vaccine.2011.03.075. Epub 2011 Apr 5.
Stimulation of acquired immunity to Salmonella in livestock is not feasible in neonates (which can be infected within 24h of birth) and is challenging in feedlots, which typically source animals from diverse locations and vendors. Induction of innate immune mechanisms through mass vaccination of animals upon arrival to feedlots is an alternative approach. Transport, environmental conditions, changes in social grouping, and further handling during feedlot assembly are significant stressors. These factors, as well as concurrent exposure to a diversity of pathogens, contribute to the risk of disease. We have shown that oral immunization of calves with a modified live Salmonella enterica serovar Typhimurium vaccine strain, which lacks the DNA adenine methylase gene (S. Typhimurium dam), attenuates the severity of clinical disease, reduces fecal shedding, and promotes clearance of salmonellae following virulent homologous and heterologous challenge. This study examines the safety and efficacy of a S. Typhimurium dam vaccine in sheep via oral delivery in drinking water (ad libitum), as a means to effectively vaccinate large groups of animals. Adult merino sheep were vaccinated in drinking water -28 days, -7 days and 24h pre and 24h post-virulent Salmonella Typhimurium challenge which was administered via the oral route. Significant attenuation of clinical disease (temperature, appetite, and attitude) and reduction in mortality and virulent Salmonella Typhimurium fecal shedding and tissue colonization was observed in animals that received the vaccine 28 and 7 days pre-challenge. Further, vaccination did not pose a risk to stock previously infected with virulent salmonellae as mortalities and clinical disease in sheep vaccinated prior to or following virulent challenge did not differ significantly from the non-vaccinated controls. The capacity of S. Typhimurium dam vaccines delivered in drinking water to protect livestock from virulent Salmonella challenge offers an effective, economical, stressor free Salmonella prophylaxis for intensive livestock production systems.
刺激家畜对沙门氏菌的获得性免疫在新生儿中是不可行的(新生儿在出生后 24 小时内即可感染),在饲养场中也具有挑战性,因为饲养场通常从不同的地点和供应商采购动物。通过在饲养场接收动物时对动物进行大规模疫苗接种来诱导先天免疫机制是一种替代方法。运输、环境条件、社会群体的变化以及在饲养场组装过程中的进一步处理都是重大应激源。这些因素以及同时接触多种病原体,增加了患病的风险。我们已经表明,用缺乏 DNA 腺嘌呤甲基化酶基因(S. Typhimurium dam)的减毒活沙门氏菌肠炎血清型 Typhimurium疫苗株对小牛进行口服免疫,可减轻临床疾病的严重程度,减少粪便排出,并促进在受到同源和异源强毒力挑战后清除沙门氏菌。本研究通过在饮用水(随意)中口服给药,检查了口服 S. Typhimurium dam 疫苗在绵羊中的安全性和有效性,这是一种有效接种大量动物的方法。在强毒力沙门氏菌 Typhimurium攻毒前 28 天、前 7 天、前 24 小时、攻毒后 24 小时,成年美利奴绵羊通过口服途径在饮用水中接受疫苗接种。在接种疫苗 28 天和 7 天前攻毒的动物中,观察到临床疾病(体温、食欲和态度)明显减轻,死亡率降低,强毒力沙门氏菌粪便排出量和组织定植减少。此外,疫苗接种不会对先前感染强毒力沙门氏菌的牲畜构成风险,因为在强毒力攻毒之前或之后接种疫苗的绵羊的死亡率和临床疾病与未接种疫苗的对照组没有显著差异。通过饮用水接种 S. Typhimurium dam 疫苗保护牲畜免受强毒力沙门氏菌攻毒的能力为集约化畜牧业生产系统提供了一种有效、经济、无应激的沙门氏菌预防措施。